Vanguard Health Care Fund Buys Centene Corp, Daiichi Sankyo Co, bluebird bio Inc, Sells Essilorluxottica, The Medicines Co, WellCare Health Plans Inc

• New Purchases: RETA, ASND, SRPT, GNDI3,
• Added Positions: CNC, 4568, BLUE, QGEN, 4503, BIIB, ARGX, LLY, AGIO, ELAN, REGN, PHIA, MOH, PFE, NOVN, NVST, 4502, TFX, SN., BAX, 4543, NMC, ALKS, IRWD,
• Reduced Positions: BMY, AZN, 4519, MRK, SGEN, ROG, VRTX, BSX, UHS, MCK, CERN, UNH, ALNY, DHR, A, CVS, ZBH, INCY, TMO, 02359, GLPG, ARE, ILMN, EW, HCA, HRC, IQV,
• Sold Out: EL, MDCO, WCG, IONS, PODD, 4507, IDIA, CYCN,

For the details of Vanguard Health Care Fund's stock buys and sells, go to https://www.gurufocus.com/guru/vanguard+health+care+fund/current-portfolio/portfolio

1. UnitedHealth Group Inc (UNH) - 9,564,836 shares, 6.02% of the total portfolio. Shares reduced by 2.3%
2. AstraZeneca PLC (AZN) - 27,423,317 shares, 5.88% of the total portfolio. Shares reduced by 7.29%
3. Bristol-Myers Squibb Company (BMY) - 40,431,799 shares, 5.56% of the total portfolio. Shares reduced by 19.55%
4. Pfizer Inc (PFE) - 56,195,374 shares, 4.72% of the total portfolio. Shares added by 1.99%
5. Eli Lilly and Co (LLY) - 16,717,681 shares, 4.71% of the total portfolio. Shares added by 2.78%

Vanguard Health Care Fund initiated holding in Reata Pharmaceuticals Inc. The purchase prices were between $74.57 and $217.92, with an estimated average price of $184.77. The stock is now traded at around $218.79. The impact to a portfolio due to this purchase was 0.25%. The holding were 574,907 shares as of .

Vanguard Health Care Fund initiated holding in Ascendis Pharma A/S. The purchase prices were between $91.45 and $139.12, with an estimated average price of $111.7. The stock is now traded at around $135.10. The impact to a portfolio due to this purchase was 0.18%. The holding were 603,093 shares as of .

Vanguard Health Care Fund initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $77.69 and $135.58, with an estimated average price of $101.97. The stock is now traded at around $115.96. The impact to a portfolio due to this purchase was 0.13%. The holding were 463,410 shares as of .

Vanguard Health Care Fund initiated holding in Notre Dame Intermedica Participacoes SA. The purchase prices were between $53.5 and $69.14, with an estimated average price of $60.31. The stock is now traded at around $69.31. The impact to a portfolio due to this purchase was 0.06%. The holding were 1,550,250 shares as of .

Vanguard Health Care Fund added to a holding in Centene Corp by 88.75%. The purchase prices were between $42.73 and $63.65, with an estimated average price of $54.66. The stock is now traded at around $62.81. The impact to a portfolio due to this purchase was 0.55%. The holding were 8,635,100 shares as of .

Vanguard Health Care Fund added to a holding in Daiichi Sankyo Co Ltd by 52.98%. The purchase prices were between $6496 and $7508, with an estimated average price of $6914.79. The stock is now traded at around $7441.00. The impact to a portfolio due to this purchase was 0.34%. The holding were 7,002,630 shares as of .

Vanguard Health Care Fund added to a holding in bluebird bio Inc by 63.54%. The purchase prices were between $72.5 and $95.22, with an estimated average price of $83.99. The stock is now traded at around $79.69. The impact to a portfolio due to this purchase was 0.34%. The holding were 4,604,667 shares as of .

Vanguard Health Care Fund added to a holding in Qiagen NV by 196.68%. The purchase prices were between $25.41 and $43.1, with an estimated average price of $35.32. The stock is now traded at around $33.78. The impact to a portfolio due to this purchase was 0.3%. The holding were 6,100,700 shares as of .

Vanguard Health Care Fund added to a holding in Astellas Pharma Inc by 44.44%. The purchase prices were between $1479 and $1909.5, with an estimated average price of $1789.79. The stock is now traded at around $1950.50. The impact to a portfolio due to this purchase was 0.3%. The holding were 27,040,300 shares as of .

Vanguard Health Care Fund added to a holding in argenx SE by 57.40%. The purchase prices were between $106.59 and $164.21, with an estimated average price of $135.82. The stock is now traded at around $144.29. The impact to a portfolio due to this purchase was 0.18%. The holding were 1,418,173 shares as of .

Vanguard Health Care Fund sold out a holding in Essilorluxottica. The sale prices were between $126.5 and $141.75, with an estimated average price of $136.33.

Vanguard Health Care Fund sold out a holding in The Medicines Co. The sale prices were between $49.68 and $84.94, with an estimated average price of $67.5.

Vanguard Health Care Fund sold out a holding in WellCare Health Plans Inc. The sale prices were between $258.37 and $332.8, with an estimated average price of $301.65.

Vanguard Health Care Fund sold out a holding in Ionis Pharmaceuticals Inc. The sale prices were between $53.85 and $65.27, with an estimated average price of $59.73.

Vanguard Health Care Fund sold out a holding in Insulet Corp. The sale prices were between $144.81 and $186, with an estimated average price of $167.06.

Vanguard Health Care Fund sold out a holding in Shionogi & Co Ltd. The sale prices were between $5867 and $6901, with an estimated average price of $6355.39.

Vanguard Health Care Fund reduced to a holding in Seattle Genetics Inc by 30.74%. The sale prices were between $79.97 and $121.62, with an estimated average price of $106.73. The stock is now traded at around $108.39. The impact to a portfolio due to this sale was -0.27%. Vanguard Health Care Fund still held 2,959,944 shares as of .

Vanguard Health Care Fund reduced to a holding in Roche Holding AG by 20.7%. The sale prices were between $281.55 and $317.25, with an estimated average price of $298.92. The stock is now traded at around $327.10. The impact to a portfolio due to this sale was -0.23%. Vanguard Health Care Fund still held 1,242,812 shares as of .